Frequency of Platelets Transfusion & Post-Operative Bleeding Risk in Patients on Clopidogrel Undergoing CABG

NCT07600060 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 227

Last updated 2026-05-20

No results posted yet for this study

Summary

The goal of this retrospective cohort study Is to Primarily be platelet transfusion frequency and postoperative bleeding risk, analysis using descriptive and inferential statistics in all eligible patients admitted to the cardiac intensive care unit (CICU) for open-heart surgery were included of both gender, age group of 30-80 years. The main questions it aims to answer are:

* How was the frequency of platelet transfusion during the index admission evaluated?
* How was post-operative bleeding risk measured?
* What does 24-hour chest drain output indicate in this context?
* How was packed cell volume (PCV) transfusion used as an outcome measure?

Conditions

  • Patients on Clopidogrel
  • Platelets Transfusion

Sponsors & Collaborators

  • Aga Khan University

    lead OTHER

Principal Investigators

  • Khalid Siddiqui, MBBS-FCPS · Aga Khan University

  • Khalid Siddiqui · Aga Khan University

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2023-05-31
Completion
2023-06-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07600060 on ClinicalTrials.gov